It’s a sign of the lucrative times in the biopharma industry that the pay for Regeneron’s co-founders and top two executives—Len Schleifer, M.D., Ph.D., and George Yancopoulos, M.D., Ph.D.—seems unusually low.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,